This is a discussion on Information for Healthcare Professionals: Cefepime (marketed as Maxipime) within the FDA News forum, part of the Industry News and Updates category; The purpose of this communication is to share information about the FDA’s continuing safety review about the potential increased ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
The purpose of this communication is to share information about the FDA’s continuing safety review about the potential increased mortality in patients treated with cefepime. Cefepime is a cephalosporin antibacterial and is a member of the ?–lactam class of antibacterial drugs.
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA issues Information for Healthcare Professionals for Insulin Pens | industry_news | FDA News | 0 | 03-19-2009 01:21 PM |
| Information for Healthcare Professionals Phenytoin and Fosphenytoin Sodium | industry_news | FDA News | 0 | 11-24-2008 05:31 PM |
| FDA issues an Information for Healthcare Professionals sheet for Amiodarone and Simvastatin. | industry_news | FDA News | 0 | 08-08-2008 12:51 PM |
| FDA issues an Information for Healthcare Professionals sheet for antipsychotics | industry_news | FDA News | 0 | 06-16-2008 06:05 PM |
| FDA updates information to healthcare facilities and healthcare professionals about heparin and heparin-containing medic | industry_news | FDA News | 0 | 04-25-2008 11:59 PM |